ResearcherFirst Affiliated Hospital of Xiamen UniversityActive in the last 2 years

Jianhua Wang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5157967738. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

Dual-pathway blockade overcomes ferroptosis resistance in pancreatic ductal adenocarcinoma via a CD133-targeted manganese-porphyrin theranostic nanoplatform. Last author DOI 10.1016/j.biomaterials.2026.124340 ↗
The prognostic value of VISTA combined with imaging in pancreatic cancer patients Last author DOI 10.21203/rs.3.rs-3855646/v1 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kaiwei Xu · 1 shared paper, 2026 · strength 0.27
- Paper Dual-pathway blockade overcomes ferroptosis resistance in pancreatic ductal adenocarcinoma via a CD133-targeted mangane… DOI 10.1016/j.biomaterials.2026.124340 ↗
Aiguo Wu · 1 shared paper, 2026 · strength 0.27
- Paper Dual-pathway blockade overcomes ferroptosis resistance in pancreatic ductal adenocarcinoma via a CD133-targeted mangane… DOI 10.1016/j.biomaterials.2026.124340 ↗
Lubing Zhu · 1 shared paper, 2024 · strength 0.21
- Paper The prognostic value of VISTA combined with imaging in pancreatic cancer patients DOI 10.21203/rs.3.rs-3855646/v1 ↗
Kaiwei Xu · 1 shared paper, 2024 · strength 0.21
- Paper The prognostic value of VISTA combined with imaging in pancreatic cancer patients DOI 10.21203/rs.3.rs-3855646/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.